• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Taysha Gene Therapies, Inc. - Common Stock (NQ:TSHA)

    3.890 +0.060 (+1.57%)
    Streaming Delayed Price Updated: 9:43 AM EST, Nov 10, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Taysha Gene Therapies, Inc. - Common Stock

    < Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
    Top stock movements in today's session.
    Keep an eye on the top gainers and losers in Monday's session, as they reflect the most notable price movements. 
    Via Chartmill
    Monday's session: top gainers and losers
    Wondering how the US markets performed in the middle of the day on Monday? Discover the movers and shakers of today's session in our comprehensive analysis. 
    Via Chartmill
    12 Health Care Stocks Moving In Monday's Intraday Session
     
    Via Benzinga
    Earnings Scheduled For February 26, 2025
     
    Via Benzinga
    Assessing Taysha Gene Therapies: Insights From 8 Financial Analysts
     
    Via Benzinga
    Expert Outlook: Taysha Gene Therapies Through The Eyes Of 7 Analysts
     
    Via Benzinga
    Earnings Scheduled For November 13, 2024
     
    Via Benzinga
    Preview: Taysha Gene Therapies's Earnings
     
    Via Benzinga
    These stocks are gapping in today's session
    Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Monday. Let's explore the market movements and identify the stocks with significant gaps. 
    Via Chartmill
    Dow Gains Over 100 Points; NewGenIvf Group Shares Plummet
     
    Via Benzinga
    Topics Stocks
    Hillenbrand Posts Better-Than-Expected Earnings, Joins Beazer Homes, Tapestry, Walt Disney And Other Big Stocks Moving Higher On Thursday
     
    Via Benzinga
    Advance Auto Parts Posts Weak Results, Joins Harrow, Taysha Gene Therapies And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
     
    Via Benzinga
    Peeling Back The Layers: Exploring Taysha Gene Therapies Through Analyst Insights
     
    Via Benzinga
    Where Taysha Gene Therapies Stands With Analysts
     
    Via Benzinga
    Neurogene Stock Plummets 44%: Is All Hope Lost for This Biotech?"
    Neurogene has been on a huge run in 2024. That came to a halt after the company released trial results. But, the results may be better than the market thinks. 
    Via MarketBeat
    Why DLocal Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
     
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
     
    Via Benzinga
    Dow Dips Over 200 Points; Home Depot Posts Upbeat Earnings
     
    Via Benzinga
    Topics Stocks
    Tyson Foods Posts Better-Than-Expected Earnings, Joins Shopify, Sea, Buckle And Other Big Stocks Moving Higher On Tuesday
     
    Via Benzinga
    Why Grab Holdings Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
     
    Via Benzinga
    TSHA Stock Earnings: Taysha Gene Therapies Beats EPS, Misses Revenue for Q2 2024
    TSHA stock results show that Taysha Gene Therapies beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. 
    Via InvestorPlace
    Why Is Taysha Gene Therapies (TSHA) Stock Down 14% Today?
    Taysha Gene Therapies stock is down on Wednesday after the company announced a proposed public offering for TSHA shares. 
    Via InvestorPlace
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
    It's time to dive into the biggest pre-market stock movers as we check out all of the latest news happening on Wednesday morning! 
    Via InvestorPlace
    Worthington Enterprises Posts Downbeat Results, Joins Taysha Gene Therapies, General Mills And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
     
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Intraday Session
     
    Via Benzinga
    S&P 500 Edges Higher; America's Car-Mart Shares Tumble After Q4 Earnings
     
    Via Benzinga
    Topics Stocks
    Why Quantum Shares Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
     
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Intraday Session
     
    Via Benzinga
    Crude Oil Rises 1%; DermTech Shares Plummet
     
    Via Benzinga
    What's Going On With Taysha Gene Therapies Stock Tuesday?
    Taysha Gene Therapies reveals promising longer-term and initial clinical data from their REVEAL Phase 1/2 trials evaluating TSHA-102 for Rett syndrome. 
    Via Benzinga
    < Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.